focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Prospectus

20 Sep 2021 17:21

RNS Number : 3691M
Maven Income and Growth VCT 3 PLC
20 September 2021
 

Joint Announcement by Maven Income and Growth VCT 3 PLC and Maven Income and Growth VCT 4 PLC

Offers for Subscription

20 September 2021

 

The Board of Directors of Maven Income and Growth VCT 3 PLC ("Maven VCT 3") and Maven Income and Growth VCT 4 PLC ("Maven VCT 4") (together the "Companies" and each a "Company") are pleased to announce that they have published a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares of 10p each in each of the Companies to raise, in aggregate, up to £20 million with over-allotment facilities of up to, in aggregate, a further £20 million (before issue costs) (the "Offers" and each an "Offer").

 The Companies have also published a joint Circular (the "Circular") seeking the approval of their respective shareholders for various matters, including obtaining shareholder approval of allotment and disapplication authorities in connection with the Offers, each Company giving notice of a General Meeting to be held on 20 October 2021 (the "General Meeting").

The Offers will open on 20 September 2021 and the deadline for receipt of applications is 12.00 noon on 4 April 2022 in relation to the tax year 2021/22 and 12.00 noon on 27 May 2022 in relation to the tax year 2022/23. The Offers will close on 3 June 2022 unless the relevant Offer is fully subscribed by an earlier date or previously extended by the relevant Board to no later than 9 September 2022. 

Each Offer is conditional on the passing of certain resolutions at the relevant General Meeting.

Pursuant to individual offer agreements dated 19 September 2021 relating to each Offer between, among others, each relevant Company and Maven Capital Partners LLP ("Maven"), Maven, as the administrator of each Offer, will receive an offer administration fee of 2.5% of the application amount in relation to each accepted application, with reductions to the fee applying in certain cases (for instance, early applications under the Offers). Maven, as the investment manager of each Company, is a related party of each Company under the Listing Rules, and the payment of such a fee by the Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

Further, pursuant to a deed of variation dated 20 September 2021 between Maven VCT 3 and Maven, both parties have agreed to vary the terms of the relevant management and administration deed, dated 1 December 2015, to remove the cap of £890,000 (in any rolling twelve month period) on the payment of performance incentive fees to Maven. It is proposed that cap is removed with effect from 1 December 2021. Since Maven is the investment manager of Maven VCT 3 and is, therefore, a related party of Maven VCT 3 under the Listing Rules, the entry into the deed of variation is a related party transaction which requires approval of the shareholders of Maven VCT 3 under Listing Rule 11.

To obtain a copy of the Securities Note, private investors and financial advisers should call Maven Capital Partners LLP on 0141 306 7400. A downloadable version of the Securities Note will shortly be available from the Maven website: www.mavencp.com/vctoffer.

Copies of the Prospectus and Circular are available, free of charge, from Maven Capital Partners UK LLP at Kintyre House, 205 West George Street, Glasgow G2 2LW.

Copies of the Prospectus and the Circular have been submitted to the National Storage Mechanism and will shortly be available for viewing online at the following website address: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Any enquiries in respect of this announcement should be directed to:

Maven Capital Partners UK LLPTelephone: 0141 306 7400

E-mail: enquiries@mavencp.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIBLGDCIBDDGBG
Date   Source Headline
7th Sep 20213:08 pmRNSStatement re Dividend Investment Scheme
16th Aug 20214:08 pmRNSTransaction in Own Shares
13th Aug 20212:13 pmRNSHalf-year Report
5th Aug 20214:39 pmRNSTransaction in Own Shares
3rd Aug 202111:31 amRNSStatement re NAV and Interim Dividend
16th Jun 20213:16 pmRNSStatement re Offer for Subscription
16th Apr 202110:25 amRNSIssue of Equity
15th Apr 20214:30 pmRNSTransaction in Own Shares
13th Apr 20212:22 pmRNSStatement re Dividend Investment Scheme
12th Apr 20219:00 amRNSNet Asset Value(s)
7th Apr 202112:28 pmRNSResult of AGM
5th Mar 20214:39 pmRNSFinal Results
29th Jan 20212:55 pmRNSTransaction in Own Shares
22nd Jan 20213:17 pmRNSNAV and Proposed Final Dividend
17th Nov 20204:29 pmRNSTransaction in Own Shares
16th Nov 20204:55 pmRNSTransaction in Own Shares
11th Nov 20204:58 pmRNSNet Asset Value(s)
28th Aug 202010:28 amRNSIssue of Equity
26th Aug 20205:23 pmRNSTransaction in Own Shares
21st Aug 20204:10 pmRNSStatement re NAV and DIS
29th Jul 20204:45 pmRNSTransaction in Own Shares
28th Jul 20204:44 pmRNSTransaction in Own Shares
24th Jul 20203:23 pmRNSHalf-year Report
9th Jul 202010:00 amRNSIssue of Equity
29th Jun 20205:25 pmRNSStatement re NAV and Interim Dividend
8th Jun 20209:33 amRNSAllotment Update
15th May 20204:55 pmRNSTransaction in Own Shares
7th May 20204:35 pmRNSPublication of Suppl.Prospcts
8th Apr 20203:56 pmRNSStatement re Offer for Subscription
8th Apr 202012:38 pmRNSResult of AGM
26th Mar 20205:25 pmRNSUpdate on Net Asset Value
26th Mar 20205:00 pmRNSAllotment Update & Suspension of DIS
19th Mar 20204:30 pmRNSAGM Update – Notification of Change of Venue
10th Mar 20204:41 pmRNSAnnual Financial Report
19th Feb 20204:09 pmRNSTransaction in Own Shares
5th Feb 202010:36 amRNSDirector/PDMR Shareholding
5th Feb 202010:32 amRNSIssue of Equity
28th Jan 202011:40 amRNSStatement re Offer for Subscription
20th Jan 20205:12 pmRNSTransaction in Own Shares
17th Jan 20204:45 pmRNSTransaction in Own Shares
17th Jan 202012:22 pmRNSNet Asset Value and Proposed Final Dividend
10th Dec 201912:28 pmRNSResult of General Meeting
4th Dec 20199:45 amRNSStatement re Share Premium Account Cancellation
20th Nov 20194:26 pmRNSTransaction in Own Shares
14th Nov 20196:20 pmRNSStatement re Offer for Subscription
24th Oct 20194:06 pmRNSTransaction in Own Shares
23rd Oct 20194:43 pmRNSNet Asset Value(s)
2nd Sep 20193:34 pmRNSDirector/PDMR Shareholding
2nd Sep 20193:26 pmRNSIssue of Equity
30th Aug 20194:27 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.